The impacts of visitor restrictions for palliative patients during the COVID-19 pandemic on family members and healthcare providers: a Canadian qualitative study.

Publication date: Jul 01, 2025

Visitor restrictions to healthcare facilities were enacted throughout the course of the COVID-19 pandemic and changed over time. Further research on the consequences of restrictions, particularly in relation to palliative care and from multiple key stakeholder perspectives, is needed. We investigated the impact of COVID-19 visitor restrictions on family members of patients with a life limiting diagnosis or who received palliative care during the pandemic, and health care providers (HCPs) for patients with life limiting diagnoses within New Brunswick, Canada. Semi-structured interviews were conducted with 12 family members and 11 HCPs. Reflexive thematic analysis was used to allow for the inductive generation of themes from the qualitative data, while investigating and comparing participants’ experiences. The analysis found that HCP and family member themes had a great deal of similarities. The themes developed for family members were: Visitor restrictions have negative impacts on palliative patients and their families; Visitor restrictions impacted patient-family care decisions and timing; Family members had more positive experiences when a patient-centred approach to care was used; Exceptions need to be made when it comes to palliative care and visitation; COVID restrictions didn’t make sense; and, COVID led to healthcare providers being further overextended. HCP themes developed were: COVID restrictions and policies impacted satisfaction with work life; The impact of not visiting on families was terrible; HCP had to figure out new ways of providing care; We believe that patients need their families; Patients are lonely and miss family; Weren’t always made clearly aware of the changes happening in hospital visitor restrictions; and, COVID restrictions led to people keeping loved ones at home. Results unveiled dynamic relationships between HCPs and family members, whose perspectives on the impacts of visitor restrictions overlapped. Main findings emphasized the overall negative impacts of visitor restrictions and a clear need to enact policies with a particular focus on understanding the need for a flexible patient and family-centred approach and quality of life considerations. Clear and consistent communication with all stakeholders regarding policies is recommended, as well as consistent exceptions for patients with life-limiting diagnoses.

Open Access PDF

Concepts Keywords
Canada Adult
Covid Aged
Healthcare Canada
Interviews Canada
Pandemic COVID-19
COVID-19 pandemic
End-of-life care
Family
Female
Health Personnel
Healthcare policy
Humans
Interviews as Topic
Life-limited diagnoses
Male
Middle Aged
New Brunswick
Palliative Care
Palliative care
Pandemic challenges
Pandemics
Qualitative Research
Qualitative research
SARS-CoV-2
Visitor restrictions
Visitors to Patients

Semantics

Type Source Name
disease MESH COVID-19 pandemic
disease IDO quality
pathway REACTOME Reproduction
disease MESH end of life
drug DRUGBANK Serine
disease MESH burnout
disease MESH compassion fatigue
drug DRUGBANK Dimercaprol
disease MESH emergency
drug DRUGBANK Trestolone
drug DRUGBANK Methylergometrine
drug DRUGBANK Methionine
drug DRUGBANK Isoxaflutole
disease MESH dementia
disease MESH loneliness
drug DRUGBANK Altretamine
disease MESH scars
drug DRUGBANK Pentaerythritol tetranitrate
drug DRUGBANK Tropicamide
drug DRUGBANK Etoperidone
disease MESH caregiver exhaustion
drug DRUGBANK Coenzyme M
disease MESH suicidal ideation
drug DRUGBANK Tretamine
disease MESH critically ill
disease IDO symptom
disease IDO intervention

Original Article

(Visited 10 times, 1 visits today)